A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease
Trial details
- Registry ID
- NCT05642442
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as CX-8998; JZP385; MK-8998
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's DiseaseNCT05642442 | Jazz Pharmaceuticals | Phase 2 | Completed | 2024-10-23Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |